Intermountain Health has become the first US health system to commercially deploy Claire, the only FDA-approved AI-enabled imaging device for margin assessment during breast-conserving breast cancer surgery. Claire helps surgeons detect microscopic cancer in real-time during surgery, reducing the need for follow-up operations. This technology enhances surgical precision by visualizing tissue suspicious for cancer beyond what the naked eye can see, potentially improving patient outcomes and lowering healthcare burdens. Claire is currently used at two Intermountain hospitals, marking a significant step in integrating AI into surgical care.
Several stocks saw significant gains due to recent financing disclosures, new analyst coverage, and leadership appointments. Antelope Enterprise Holdings rose 83% after raising nearly $19 million in a private placement. Ticketplus jumped 31% followin...
Utility stocks Edison International and PG&E Corporation fell sharply after California lawmakers passed wildfire legislation without expected liability protections, exposing utilities to costly claims. Edison dropped over 23%, nearing its 52-week low...
Scotiabank increased its price target for Palo Alto Networks to $430, suggesting a 13% upside from current levels, following a 30% surge in shares after strong Q3 results. The cybersecurity firm is expected to deliver robust Q4 performance and signif...
Mantle (MNT) trades at $0.5659, up 42.6% over the past 30 days but still down 79% from its 12-month high of $2.6896. The token shows a short-term recovery above its 50-day moving average but remains below the 200-day average, indicating the long-term...
Ryder System, Inc. continues to be a Buy due to management's effective strategies that have doubled earnings per share and improved cash flow. The company is shifting its revenue focus toward higher-value service segments, which has helped offset cha...
